Caveolin-1 expression in Schwann cells

GLIA

Volumn 27, Issue 1, 1999, Pages 39-52

  Mikol, Daniel D ^a,b   Hong, Hoylond L ^a   Cheng, Hsin Lin ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Caveolae; Cholesterol; Differentiation; Myelin; Nerve

Indexed keywords

EID: 0033168733     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-1136(199907)27:1<39::aid-glia5>3.0.co;2-%23     Document Type: Article

References (110)

1. Akert KC, Sandri C, Weibel ER, Peper K, Moor H. 1976, The fine structure of the perineural endothelium. Cell Tissue Res 165:281-295.
2. Anderson HGW. 1993. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90:10909-10913.
3. Anderson RGW, Kamen BA, Rothberg KG, Lacey SW. 1992. Potocytosis: sequestration and transport of small molecules by caveolae. Science 255:410-411.
4. Biedler JL, Spengler BA, Tien-ding C, Ross RA. 1988. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Adv Neuroblastoma Res 2:265-276.
5. Bilderback TR, Grigsby RJ, Dobrowsky RT. 1997. Association of p75NTR with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J Biol Chem 272:10922-10927.
6. Bist A, Fielding PE, Fielding CJ. 1997. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci 94:10693-10698.
7. Brockes JP, Fields KL, Raff MC. 1979. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165:105-118.
8. Brockes JP, Lemke GE, Balzer DR. 1980. Purification and preliminary characterization of a glial growth factor from bovine pituitary. J Biol Chem 255:8374-8377.
9. Bunge RP, Bunge MB, Eldridge CF. 1986. Linkage between axonal ensheathment and basal lamina production by schwann cells. Annu Rev Neurosci 9:305-328.
10. Cameron PL, Ruffin JW, Bollag R, Rasmussen H, Cameron RS. 1997. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci 17:9520-9535.
11. Cheng H-L, Russell JW, Feldman EL. 1999. Insulin-like growth factor-I promotes Schwann cell motility. Glia (in press).
12. Couet J, Sargiacomo M, Lisanti MP. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. J Biol Chem 272:30429-30438.
13. Davis JB, Stroobant P. 1990. Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. J Cell Biol 110:1353-1360.
14. Dewille JW, Horrocks LA. 1992. Synthesis and turnover of myelin phospholipids and cholesterol. In: Martenson RE, editor. Myelin: biology and chemistry. Boca Raton: CRC Press. p 213-234.
15. Doyle DD, Ambler SK, Upshaw-Earley J, Bastawrous A, Goings GE, Page E. 1997. Type B atrial natriuretic peptide receptor in cardiac myocyte caveolae. Circulation Res 81:86-91.
16. Eldridge CF, Bunge MB, Bunge RP. 1989. Differentiation of axon-related Schwann cells in vitro: II. Control of myelin formation by basal lamina. J Neurosci 9:625-638.
17. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272:16374-16381.
18. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. 1998a. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. FEBS Lett 428:205-211.
19. Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, Lisanti MP. 1998b. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. J Biol Chem 273:20448-20455.
20. Fan JY, Carpentier J-L, Van Obberghen E, Grunfeld C, Gorden P, Orci L. 1983. Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J Cell Sci 61:219-230.
21. Fielding CJ, Fielding PE. 1997b. Intracellular cholesterol transport. J Lipid Res 38:1503-1521.
22. Fielding CJ, Bist A, Fielding PE. 1997a. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94:3753-3758.
23. Fielding PE, Fielding CJ. 1995. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34:14288-14292.
24. Fra AM, Masserini M, Palestini P, Sonnino S, Simons K. 1995a. A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 375:11-14.
25. Fra AM, Williamson E, Simons K, Parton RG. 1995b. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92:8655-8659.
26. Fu Q, Goodrum JF, Hayes C, Hostettler JD, Toews AD, Morell P. 1998. Control of cholesterol biosynthesis in Schwann cells. J Neurochem 71:549-555.
27. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M, Okamoto T, Lisanti MP. 1998. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 95:10257-10262.
28. Gleizes PE, Noaillac-Depeyre J, Dupont MA, Gas N. 1996. Basic fibroblast growth factor (FGF-2) is addressed to caveolae after binding to the plasma membrane of BHK cells. Eur J Cell Biol 71:144-153.
29. Glenney JR. 1992. The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles. FEBS Lett 314:45-48.
30. Glenney JR, Soppet D. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 89:10517-10521.
31. Goodearl ADJ, Davis JB, Mistry K, Minghetti L, Otsu M, Waterfield MD, Stroobant P. 1993. Purification of multiple forms of glial growth factor. J Biol Chem 268:18095-18102.
32. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS. 1996. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107-6118.
33. Haasemann M, Cartaud J, Muller-Esterl W, Dunia I. 1998. Agonist-induced redistribution of bradykinin B2 receptor in caveolae. J Cell Sci 111:917-928.
34. Hailstones D, Sleer LS, Parton RG, Stanley KK. 1998. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 39:369-379.
35. Hall SM, Williams PL. 1971. The distribution of electron-dense tracers in peripheral nerve fibres. J Cell Sci 8:541-555.
36. Hansson HA, Dahlin LB, Danielsen N, Fryklund L, Nachemson AK, Polleryd P, Rozell B, Skottner A, Stemme S, Lundborg, G. 1986. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol Scand 126:609-614.
37. Holthuizen P, vanderLee FM, Ikejiri K, Yamamoto M, Sussenbach JS. 1990. Identification and initial characterization of a fourth leader exon and promoter of the human IGF-II gene. Biochim Biophys Acta 1087:341-343.
38. Jessen KR, Mirsky R. 1991. Schwann cell precursors and their development. Glia 4:185-194.
39. Jessen KR, Mirsky R, Morgan L. 1991. Role of cyclic AMP and proliferation controls in Schwann cell differentiation. Ann. NY Acad Sci 633:78-89.
40. Jessen KR, Brennan A, Morgan L, Mirsky R, Kent A, Hashimoto Y, Gavrilovic J. 1994. The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron 12:509-527.
41. Jurevics HA, Morell P. 1994. Sources of cholesterol for kidney and nerve during development. J Lipid Res 35:112-120.
42. Jurevics H, Bouldin TW, Toews AD, Morell P. 1998. Regenerating sciatic nerve does not utilize circulating cholesterol. Neurochem Res 23:401-406.
43. Koleske AJ, Baltimore D, Lisanti MP. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92:1381-1385.
44. Krasnoselsky A, Massay MJ, DeFrances MC, Michalopoulos G, Zarneger R, Ratner N. 1994. Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J Neurosci 14:7284-7290.
45. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
46. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. 1998. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16:1391-1397.
47. Lemke G, Chao M. 1988. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development 102:499-504.
48. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP. 1995. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270:15693-15701.
49. Li S, Couet J, Lisanti MP. 1996a. Src tyrosine kinases, Ga subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. J Biol Chem 271:29182-29190.
50. Li S, Song KS, Lisanti MP. 1996b. Expression and characterization of recombinant caveolin. J Biol Chem 271:568-573.
51. Lisanti MP, Tang ZL, Sargiacomo M. 1993. Caveolin forms a heterooligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol 123:595-604.
52. Lisanti MP, Scherer PE, Tang Z-L, Sargiacomo M. 1994a. Caveolae, caveolin, and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol 4:231-235.
53. Lisanti MP, Scherer PE, Vicugiriene J, Tang Z-L, Hermanowski M, Vosatka A, Tu Y-H, Cook RF, Sargiacomo M. 1994b. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126:111-126.
54. Lisanti MP, Scherer PE, Tang, Z-L, Kubler E, Koleske AJ, Sargiacomo M. 1995a. Caveolae and human disease: functional roles in transcytosis, potocytosis, signalling and cell polarity. Semin Dev Biol 6:47-58.
55. Lisanti MP, Tang Z-L, Scherer PE, Sargiacomo M. 1995b. Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. Methods Enzymol 250:655-668.
56. Lisanti MP, Tang Z, Scherer PE, Kubler E, Koleske AJ, Sargiacomo M. 1995c. Caveolae, transmembrane signalling and cellular transformation. Mol Membr Biol 12:121-124.
57. Liu P, Ying Y, Ko Y-G, Anderson RGW. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 271:10299-10303.
58. Mastick CC, Saltiel AR. 1997. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J Biol Chem 272:20706-20714.
59. Mikol DD, Feldman EL. 1997. The oligodendrocyte-myelin glycoprotein is present in a subcompartment of myelin. Neurology Suppl 48:37.
60. Mikol DD, Stefansson K. 1988. A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and oligodendrocytes. J Cell Biol 106:1273-1279.
61. Mirsky R, Jessen KR. 1990. Schwann cell development and the regulation of myelination. Semin Neurosci 2:423-435.
62. Montesano R, Roth J, Robert A, Orci L. 1982. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 296:651-653.
63. Mugnaini E, Osen KK, Schnapp B, Friedrich VL. 1977. Distribution of Schwann cell cytoplasm and plasmalemmal vesicles (caveolae) in peripheral myelin sheaths. An electron microscopic study with thin sections and freeze-fracturing. J Neurocytol 6:647-668.
64. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K. 1995. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92:10339-10343.
65. Nakao J, Shinoda J, Nakai Y, Murase S, Uyemura K. 1997. Apoptosis regulates the number of Schwann cells at the premyelinating stage. J Neurochem 68:1853-1862.
66. Norton WT, Poduslo SE. 1973, Myelination in rat brain: method of myelin isolation. J Neurochem 21:749-757.
67. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422.
68. Olsson Y, Reese TS. 1971. Permeability of vasa nervosum and perineurium in mouse sciatic nerve studied by fluorescence and electron microscopy. J Neuropathol Exp Neurol 30:105-119.
69. Owens GC, Bunge RP. 1989. Evidence for an early role for myelin-associated glycoprotein in the process of myelination. Glia 2:119-128.
70. Parton RG. 1994. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 42:155-166.
71. Peden KWC, Charles C, Sanders L, Tennekoon GI. 1989. Isolation of rat schwann cell lines: use of SV40 T antigen gene regulated by synthetic metallothionein promoters. Exp Cell Res 185:60-72.
72. Porter S, Clark MB, Glaser L, Bunge RP. 1986. Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability. J Neurosci 6:3070-3078.
73. Reale E, Luciano L, Spitznas M. 1975. Freeze-fracture faces of the perineurial sheath of the rabbit sciatic nerve. J Neurocytol 4:261-270.
74. Ridley AJ, Davis JB, Stroobant P, Land H. 1989. Transforming growth factors-b1 and b2 are mitogens for rat Schwann cells. J Cell Biol 109:3419-3424.
75. Rothberg KG, Ying Y, Kamen BA, Anderson RGW. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 111:2931-2938.
76. Rothberg KG, Heuser JE, Donzell WC, Ying Y, Glenney JR, Anderson RGW. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.
77. Russell JW, Windebank AJ, Schenone A, Feldman EL. 1998. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 36:455-467.
78. Sandri C, Van Buren JM, Akert K. 1977. Mesenchymal structures in the nervous system. In: Membrane morphology of the vertebrate nervous system. Amsterdam: Elsevier. p 325-361.
79. Sargiacomo M, Sudol M, Tang Z-L, Lisanti MP. 1993. Signal transducing molecules and glycosyl-phosphatidylinositol-lined proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.
80. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC, Lisanti MP. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 92:9407-9411.
81. Sasagasako N, Toda K, Hollis M, Quarles RH. 1996. Myelin gene expression in immortalized Schwann cells: relationship to cell density and proliferation. J Neurochem 66:1432-1439.
82. Scheiffele P, Verkade P, Fra AM, Virta H, Simons K, Ikonen E. 1998. Caveolin-1 and -2 in the exocytic pathway of MDCK cells. J Cell Biol 140:795-806.
83. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Corley Mastick C, Lodish HF. 1994. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 127: 1233-1243.
84. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP. 1995. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. J Biol Chem 270:16395-16401.
85. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. 1996. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 93:131-135.
86. Scherer SS, Asbury AK. 1993. Inherited axonal neuropathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunkle LM, editors. The molecular and genetic basis of neurological disease. Butterworth-Heinemann. p 899-921.
87. Scherer SS, Salzer JL. 1996. Axon-Schwann cell interactions during peripheral nerve degeneration and regeneration. In: Jessen KR, Richardson WD, editors. Glial cell development. Oxford, UK: BIOS Scientific Publishers Limited. p 165-196.
88. Scherer SS, Deschenes SM, Xu Y, Grinspan JB, Fischbeck KH, Paul DL. 1995. Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 15:8281-8294.
89. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P. 1995. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269:1435-1439.
90. Severs NJ. 1988. Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci 90:341-348.
91. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, Michel, T. 1996. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem.271: 6518-6522.
92. Simionescu N. 1983. Cellular aspects of transcapillary exchange. Physiol Rev 63:1536-1571.
93. Simionescu N, Lupu F, Simionescu M. 1983. Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium. J Cell Biol 97:1592-1600.
94. Simons K, Wandinger-Ness A. 1990. Polarized sorting in epithelia. Cell 62:207-210.
95. Smart EJ, Ying Y-S, Mineo C, Anderson RGW. 1995. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92:10104-10108.
96. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. 1996a. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J Biol Chem 271:9690-9697.
97. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. 1996b. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J Biol Chem 271:15160-15165.
98. Stewart HJS, Mirsky R, Jessen KR. 1996. The Schwann cell lineage: embryonic and early postnatal development. In: Jessen KR, Richardson WD, editors. Glial cell development. Oxford, UK: BIOS Scientific Publishers Limited. p 1-30.
99. Syroid DE, Maycox PR, Burrola PG, Liu NL, Wen DZ, Lee KF, Lemke G, Kilpatrick TJ. 1996. Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci USA 93:9229-9234.
100. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261.
101. Uittenbogaard A, Ying Y, Smart EJ. 1998. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. J Biol Chem 273:6525-6532.
102. Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T. 1994. Initial events of myelination involveFyn tyrosine kinase signalling. Nature 367:572-576.
103. Verity AN, Bredesen D, Vonderscher C, Handley VW, Campagnoni AT. 1993. Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus. J Neurochem 60:577-587.
104. Waggener JD, Bunns SM, Beggs J. 1965. The diffusion of ferritin within the peripheral nerve sheath: an electron microscopic study. J Neuropathol Exp Neurol 24:430-443.
105. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG. 1996. The adapter protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87:733-743.
106. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. 1998. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-634.
107. Webster H. 1993. Development of peripheral nerve fibers. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Podulso JF, editors. Peripheral neuropathy. Philadelphia: Saunders. p 243-266.
108. Wood PM, Schachner M, Bunge RP. 1990. Inhibition of Schwann cell myelination in vitro by antibody to the L1 adhesion molecule. J Neurosci 10:3635-3645.
109. Wu C, Butz S, Ying Y, Anderson RGW. 1997. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J Biol Chem 272:3554-3559.
110. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers Jr MG, Ishikawa Y. 1998. Caveolin is an activator of insulin receptor signaling. J Biol Chem 273:26962-26968.